Online edition of India's National Newspaper
Wednesday, Apr 07, 2004

About Us
Contact Us
Business
News: Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous |
Advts:
Classifieds | Employment |

Business - Briefly Printer Friendly Page   Send this Article to a Friend

Lupin launches Suprax in U.S.

MUMBAI, APRIL 6. Lupin launched its anti-infective product, Suprax, (cefixime Oral Suspension) in the US. The newly established 50 paediatric salesforce of the company's subsidiary, Lupin Pharmaceuticals Inc. (LPI), has begun detailing Suprax. The sales will initially target over 10,000 physicians who prescribe oral suspension anti-infectives. The market for branded anti-infectives' oral suspension is over $1 billion.

— Our Special Correspondent

Printer friendly page  
Send this article to Friends by E-Mail

Business

News: Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous |
Advts:
Classifieds | Employment | Updates: Breaking News |


News Update


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | Home |

Copyright 2004, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu